ENSYSCE BIOSCIENCES, INC. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
ENSYSCE BIOSCIENCES, INC. (ENSC) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $2.00 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2026-03-30
- 2025-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $2.00M.
- 2024-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $1.80M.
- 2023-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $1.70M.
- 2022-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $1.40M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate |
|---|---|
| 2025-12-31 | $2.00M 10-K · filed 2026-03-30 |
| 2024-12-31 | $1.80M 10-K · filed 2026-03-30 |
| 2023-12-31 | $1.70M 10-K · filed 2025-03-10 |
| 2022-12-31 | $1.40M 10-K · filed 2024-03-15 |
| 2021-12-31 | $1.10M 10-K · filed 2023-03-30 |
| 2020-12-31 | $1.00M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |